Published on 7 Nov 2023 on GuruFocus.com via Yahoo Finance
Mesa Laboratories Inc (NASDAQ:MLAB) reports a 9.5% decrease in total revenues for Q2 FY 2024 compared to Q2 FY 2023.Adjusted Operating Income (AOI) excluding unusual items decreased by 29.1% quarter over quarter.Company's net loss for Q2 FY 2024 was $1,230, a decrease of 194% compared to Q2 FY 2023.Mesa Laboratories Inc (NASDAQ:MLAB) implemented cost control actions expected to generate annual savings of approximately $2,000 starting in 3Q24.
Warning! GuruFocus has detected 7 Warning Signs with MLAB.
On November 6, 2023, Mesa Laboratories Inc (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, announced its second fiscal quarter results for the period ended September 30, 2023.